BOTHELL, WA--(Marketwire - October 28, 2008) - MDRNA, Inc. (NASDAQ: MRNA) announced today that Barry Polisky, Ph.D., will join the Company as Chief Scientific Officer on January 2, 2009. Dr. Polisky replaces Steven C. Quay, M.D., Ph.D., Chief Scientific Officer, Chairman of the Board of Directors and Chairman of the Scientific Advisory Board, who will be leaving the Company on November 30, 2008. Dr. Quay will continue to serve as a member of the Board of Directors and a member of the Scientific Advisory Board. Dr. Polisky, who previously served as Research Vice President, Merck & Co., and as Chief Scientific Officer at Sirna Therapeutics, will oversee all research personnel and scientific activities. Dr. Polisky will report to J. Michael French, President and CEO.
